9.49

0.74% 0.07

After Hours: 9.50 0.010 +0.11%

Clearpoint Neuro Inc (CLPT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Clearpoint Neuro Inc stock is traded at $9.49, with a volume of 591.97K. It is up +0.74% in the last 24 hours and down -37.40% over the past month. ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

Previous Close:

$9.42

Open:

$9.63

24h Volume:

591.97K

Relative Volume:

0.75

Market Cap:

$281.51M

Revenue:

$36.97M

Net Income/Loss:

$-25.54M

P/E Ratio:

-10.52

EPS:

-0.9022

Net Cash Flow:

$-24.45M

1W Performance:

-1.20%

1M Performance:

-37.40%

6M Performance:

-51.93%

1Y Performance:

-27.94%

1-Day Range:

$9.34

$9.90

1-Week Range:

$8.93

$9.90

52-Week Range:

$8.63

$30.10

Clearpoint Neuro Inc Stock (CLPT) Company Profile

Name

Clearpoint Neuro Inc

Sector

Healthcare (1114)

Industry

Medical Devices (143)

Phone

(949) 900-6833

Address

120 S. SIERRA AVENUE, SOLANA BEACH, CA

Employee

172

Twitter

@intent

Next Earnings Date

2026-03-17

Latest SEC Filings

CLPT's Discussions on Twitter

Compare CLPT vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLPT Clearpoint Neuro Inc	9.49	279.43M	36.97M	-25.54M	-24.45M	-0.9022
ABT Abbott Laboratories	104.83	180.82B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.65	125.72B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.89	111.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.78	101.28B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	82.67	47.45B	6.07B	1.06B	1.34B	1.8063

Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-25-24	Resumed	B. Riley Securities	Buy
Oct-24-23	Initiated	Stifel	Buy
Feb-16-23	Resumed	B. Riley Securities	Buy
Apr-05-22	Resumed	B. Riley Securities	Buy
Mar-18-21	Initiated	Lake Street	Buy
Jul-17-20	Initiated	B. Riley FBR	Buy

View All

Clearpoint Neuro Inc Stock (CLPT) Latest News

Mar 25, 2026

Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN

Mar 25, 2026

Mar 23, 2026

Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance

Mar 23, 2026

Mar 22, 2026

ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan

Mar 20, 2026

Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn

Mar 20, 2026

CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill

Mar 20, 2026

Mar 19, 2026

Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail

Mar 19, 2026

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 19, 2026

Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks

Mar 19, 2026

Mar 18, 2026

ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st

Mar 18, 2026

Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com

Mar 18, 2026

ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail

Mar 18, 2026

ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat

Mar 18, 2026

ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat

Mar 18, 2026

ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus

Mar 18, 2026

Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 18, 2026

B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - marketscreener.com

Mar 18, 2026

ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN

Mar 18, 2026

ClearPoint Neuro (CLPT) Surpasses Q4 Revenue Expectations with S - GuruFocus

Mar 18, 2026

Clearpoint Neuro earnings missed by $0.08, revenue topped estimates - Investing.com Canada

Mar 18, 2026